200 related articles for article (PubMed ID: 27657514)
21. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.
Ramsay CF; Sullivan P; Gizycki M; Wang D; Swern AS; Barnes NC; Reiss TF; Jeffery PK
Respir Med; 2009 Jul; 103(7):995-1003. PubMed ID: 19249198
[TBL] [Abstract][Full Text] [Related]
22. Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study.
Gao JM; Cai F; Peng M; Ma Y; Wang B
Chin Med J (Engl); 2013 Jun; 126(12):2229-34. PubMed ID: 23786930
[TBL] [Abstract][Full Text] [Related]
23. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
24. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
[TBL] [Abstract][Full Text] [Related]
25. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK
J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
[TBL] [Abstract][Full Text] [Related]
26. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma.
Montuschi P; Mondino C; Koch P; Ciabattoni G; Barnes PJ; Baviera G
Chest; 2007 Dec; 132(6):1876-81. PubMed ID: 18079221
[TBL] [Abstract][Full Text] [Related]
27. The effect of montelukast on eosinophil apoptosis: induced sputum findings of patients with mild persistent asthma.
Abadoglu O; Mungan D; Aksu O; Erekul S; Misirligil Z
Allergol Immunopathol (Madr); 2005; 33(2):105-11. PubMed ID: 15808118
[TBL] [Abstract][Full Text] [Related]
28. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old.
Straub DA; Minocchieri S; Moeller A; Hamacher J; Wildhaber JH
Chest; 2005 Feb; 127(2):509-14. PubMed ID: 15705989
[TBL] [Abstract][Full Text] [Related]
29. Regulation of stromal cell-derived factor-1 and exhaled nitric oxide in asthmatic children following montelukast and ketotifen treatment.
Hung CH; Jong YJ; Hua YM; Li CY; Lai YS; Yang KD; Chang HC
Pulm Pharmacol Ther; 2007; 20(3):233-9. PubMed ID: 17276712
[TBL] [Abstract][Full Text] [Related]
30. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
Currie GP; Lee DK; Haggart K; Bates CE; Lipworth BJ
Am J Respir Crit Care Med; 2003 May; 167(9):1232-8. PubMed ID: 12456382
[TBL] [Abstract][Full Text] [Related]
31. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast.
Kraft M; Cairns CB; Ellison MC; Pak J; Irvin C; Wenzel S
Chest; 2006 Dec; 130(6):1726-32. PubMed ID: 17166989
[TBL] [Abstract][Full Text] [Related]
32. The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma.
Straub DA; Moeller A; Minocchieri S; Hamacher J; Sennhauser FH; Hall GL; Wildhaber JH
Eur Respir J; 2005 Feb; 25(2):289-94. PubMed ID: 15684293
[TBL] [Abstract][Full Text] [Related]
33. Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trial.
Stelmach I; Ożarek-Hanc A; Zaczeniuk M; Stelmach W; Smejda K; Majak P; Jerzynska J; Anna J
Pulm Pharmacol Ther; 2015 Apr; 31():42-8. PubMed ID: 25640020
[TBL] [Abstract][Full Text] [Related]
34. [Effect of montelukast on the expression of neurokinin-1 receptor in young asthmatic rats with airway remodeling].
Wei B; Shang YX; Li M; Zhang H
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):298-301. PubMed ID: 23607955
[TBL] [Abstract][Full Text] [Related]
35. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Pavord I; Woodcock A; Parker D; Rice L;
Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478
[TBL] [Abstract][Full Text] [Related]
36. Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
Shin IS; Jeon WY; Shin HK; Lee MY
Int Immunopharmacol; 2013 Nov; 17(3):867-73. PubMed ID: 24126112
[TBL] [Abstract][Full Text] [Related]
37. Montelukast versus formoterol as second-line therapy in asthmatic children exposed to relevant allergens.
Peroni DG; Piacentini GL; Bodini A; Ress M; Costella S; Boner AL
Allergy Asthma Proc; 2005; 26(4):283-6. PubMed ID: 16270721
[TBL] [Abstract][Full Text] [Related]
38. Effects of 24-week add-on treatment with ciclesonide and montelukast on small airways inflammation in asthma.
Nakaji H; Petrova G; Matsumoto H; Iwata T; Ito I; Oguma T; Inoue H; Tajiri T; Nagasaki T; Kanemitsu Y; Niimi A; Mishima M
Ann Allergy Asthma Immunol; 2013 Mar; 110(3):198-203.e3. PubMed ID: 23548532
[TBL] [Abstract][Full Text] [Related]
39. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
40. Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma.
Jayaram L; Duong M; Pizzichini MM; Pizzichini E; Kamada D; Efthimiadis A; Hargreave FE
Eur Respir J; 2005 Jan; 25(1):41-6. PubMed ID: 15640321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
